Oncolytic Virus Therapy Market Overview: 2022-28

Base Year: 2021

Historical Years: 2017-20

Forecast Years: 2022-27

The Oncolytic Virus Therapy Market is projected to grow at a CAGR of around 20.3% during the forecast period i.e. 2022-27. The market is driven primarily by the mounting prevalence of cancer worldwide and the surging number of clinical trials & R&D investments for cancer therapies. 

Markntel Advisor’s Oncolytic Virus Therapy Market Insights report provides the current and forecast market analysis, individual leading companies' market shares, challenges, Oncolytic Virus Therapy Market drivers, barriers, Oncolytic Virus Therapy Market Trends, and Key Players in Oncolytic Virus Therapy Market.

✅In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecast for years 2025 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.

Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report: https://www.marknteladvisors.com/query/request-sample/oncolytic-virus-therapy-market.html

Oncolytic Virus Therapy Market Dynamics: 2022-27

Increasing technological advancements in cancer treatments & the development of new therapies

Growing adoption of advanced therapeutic options & rising cancer cases

Research & Development initiatives & investments by healthcare providers

Browse Full Report with Detail Analysis - https://www.marknteladvisors.com/research-library/oncolytic-virus-therapy-market.html

Oncolytic Virus Therapy Market (2022-27): Segmentation Outlook

The market report has segmented the market into the following categories:

• By Therapy
  • IMLYGIC (Talimogene Laherparepvec)- Market Size & Forecast 2020-2030, USD Million
  • Oncorine- Market Size & Forecast 2020-2030, USD Million
  • RIGVIR Immunotherapy- Market Size & Forecast 2020-2030, USD Million
  • Onyx-15- Market Size & Forecast 2020-2030, USD Million
  • Reolysin- Market Size & Forecast 2020-2030, USD Million   
• By Application
  • Solid Tumor- Market Size & Forecast 2020-2030, USD Million
    • Breast Cancer- Market Size & Forecast 2020-2030, USD Million
    • Prostate Cancer- Market Size & Forecast 2020-2030, USD Million
    • Lung Cancer- Market Size & Forecast 2020-2030, USD Million
    • Glioblastoma/Glioblastoma Multiforme- Market Size & Forecast 2020-2030, USD Million
  • Melanoma- Market Size & Forecast 2020-2030, USD Million
  • Hematological Malignancies- Market Size & Forecast 2020-2030, USD Million
    • Lymphoma- Market Size & Forecast 2020-2030, USD Million
    • Leukemia- Market Size & Forecast 2020-2030, USD Million
    • Myeloma- Market Size & Forecast 2020-2030, USD Million

According to report, Of them all, Melanoma is anticipated to dominate the Global Oncolytic Virus Therapy Market in the coming years.

• By Type of Virus
  • Genetically Engineered Oncolytic Virus- Market Size & Forecast 2020-2030, USD Million
    • Herpes Simplex Virus(HSV)- Market Size & Forecast 2020-2030, USD Million
    • Adenovirus- Market Size & Forecast 2020-2030, USD Million
    • Vaccinia Virus- Market Size & Forecast 2020-2030, USD Million
  • Oncolytic Wild Type of Viruses- Market Size & Forecast 2020-2030, USD Million
    • Myxoma- Market Size & Forecast 2020-2030, USD Million
    • Vesicular Stomatitis Virus (VSV)- Market Size & Forecast 2020-2030, USD Million
    • Newcastle Disease Virus (NDV)- Market Size & Forecast 2020-2030, USD Million
    • Reovirus (Respiratory Enteric Orphan Virus)- Market Size & Forecast 2020-2030, USD Million
  • By End User
    • Hospitals- Market Size & Forecast 2020-2030, USD Million
    • Clinics- Market Size & Forecast 2020-2030, USD Million
    • Patients- Market Size & Forecast 2020-2030, USD Million
    • Cancer Research Institutes- Market Size & Forecast 2020-2030, USD Million
  • By Region
    • North America
    • South America
    • Europe
    • Middle East and Africa
    • Asia-Pacific

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

Top Companies Operating in the Oncolytic Virus Therapy Market:

• Amgen Inc.
• Daiichi Sankyo Company Limited
• DNAtrix
• Genelux Corporation
• Oncolytics Biotech Inc.
• PsiOxus Therapeutics
• RIGVIR Ltd.
• Shanghai Sunway Biotech Co. Ltd.
• SillaJen Inc.
• Sorrento Therapeutics Inc.
• Takara Bio Inc.
• Lokon Pharma AB
• VCN Biosciences
• ViroCure Inc.
• Viralytics Ltd. (Merck & Co. Inc.)

Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

About Us –

We are a leading market research company, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Email: [email protected]

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India